Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes, and for increasing HDL plasma levels in mammals.
Substituted heterocyclic compounds
Ibrahim, P., Shenk, K., Elzein, E., Palle, V., Zablocki, J., & Rehder, K. (2005). IPC No. U.S. Substituted heterocyclic compounds. (Patent No. 6930111).